Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00150098 · ClinicalTrials.gov registry record · NA
Project UNITY - HIV Risk Reduction and Vaccine Education Interventions
A NA study, sponsored by New York Blood Center.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT00150098: Completed NA study, sponsored by New York Blood Center.
NCT00150098 is a NA study that has completed, run by New York Blood Center. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00150098, a NA study, has completed, sponsored by New York Blood Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
To determine the efficacy of an enhanced HIV risk reduction intervention delivered concurrently with a vaccination schedule to reduce the number of unprotected vaginal and anal sex acts among HIV-negative, high-risk non-injection drug-using (NIDU) women. To determine the efficacy of an enhanced vaccine education intervention delivered at baseline to increase vaccine knowledge and understanding of a potential HIV vaccine among HIV-negative, high-risk NIDU women.
Interventions
- BEHAVIORAL Enhanced HIV risk reduction and HIV vaccine education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-02 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT00150098 record still lists
NCT00150098 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which Enhanced HIV risk reduction and HIV vaccine education is the first listed.
NCT00150098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00150098 about?
NCT00150098 is a clinical study titled "Project UNITY - HIV Risk Reduction and Vaccine Education Interventions". To determine the efficacy of an enhanced HIV risk reduction intervention delivered concurrently with a vaccination schedule to reduce the number of unprotected vaginal and anal sex acts among HIV-negative, high-risk non-injection drug-using (NIDU) women. To determine the efficacy of an enhanced vacc...
What is the current status of trial NCT00150098?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2005-02. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00150098?
The interventions under investigation include: Enhanced HIV risk reduction and HIV vaccine education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00150098?
This trial is sponsored by New York Blood Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00150098's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia